Recently, NRF2 has been shown to act on the promoter of the superoxide dismutase 2 (SOD2) gene by ChIP-qPCR analysis and to increase its mRNA and protein expression in human lung cancer cells [24,25]. This evidence concerns the gene SOD2 and lung carcinoma.